首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:European journal of breast health

缩写:

ISSN:N/A

e-ISSN:2587-0831

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引538
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lian Li,Zhi Liu,Huiling Zhang et al. Lian Li et al.
Myeloid sarcoma (MS) involving the breast is rare. We reviewed a case of a 21-year-old female with palpable masses in the bilateral breasts without medullary acute myeloid leukemia. Ultrasound revealed irregular, indistinct, and complex hyp...
Manuel López-Herrero,Mireia Pitarch,Mario Giner et al. Manuel López-Herrero et al.
Tattoo pigment may migrate to regional lymph nodes and appear as dense deposits and/or calcifications, mimicking malignant axillary findings on breast imaging. We report a breast imaging case with apparent axillary lymph node calcifications...
Eri Kato,Hideo Shigematsu,Ai Amioka et al. Eri Kato et al.
Objective: Accurate prediction of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is essential for treatment decision-making in breast cancer. The value of integrated prediction models combining int...
Peggy Rosenzweig,Margaret Quinn Rosenzweig,Xueying Pei et al. Peggy Rosenzweig et al.
Funding: Funding (NIH #1OT2OD037972-01). Objective: Artificial intelligence (AI) may enhance the efficiency and personalization of brea...
Dom Van Loggerenberg Dom Van Loggerenberg
Objective: Randomized trials and international guidelines endorse hypofractionated whole-breast irradiation (HF-WBI) as standard of care for early breast cancer, offering equivalent tumour control with shorter treatment t...
Dom Van Loggerenberg Dom Van Loggerenberg
Objective: CDK4/6 inhibitors are an established component of systemic therapy for hormone receptor-positive (HR+)/HER2- breast cancer, with proven efficacy in combination with endocrine therapy in both advanced and early-...
Bethany A Kerr,J Doug Alexander,Hui Zhao et al. Bethany A Kerr et al.
Objective: People newly diagnosed with breast cancer spend a considerable amount of time researching their diagnosis, treatment options and associated side effects. Even with access to trusted evidence-based information, ...
Lindsey J Anstine,Alexandra A Erwin,Molly L Guthrie et al. Lindsey J Anstine et al.
Objective: Inflammatory breast cancer (IBC) is a rare, highly aggressive form of advanced breast cancer that is challenging to diagnose due to its ambiguous clinical nature. Gaps in awareness in clinical and patient commu...